SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    D.W. Shin, J. Cho, D.L. Roter, S.Y. Kim, Ji.H. Park, B. Cho, H.-S. Eom, J.-S. Chung, H.-K. Yang, Jo.-H. Park, Attitudinal concordance toward uptake and disclosure of genetic testing for cancer susceptibility in patient–family member dyads, Clinical Genetics, 2014, 86, 2
  2. 2
    Herman Depypere, Joelle Desreux, Faustino R. Pérez-López, Iuliana Ceausu, C. Tamer Erel, Irene Lambrinoudaki, Karin Schenck-Gustafsson, Yvonne T. van der Schouw, Tommaso Simoncini, Florence Tremollieres, Margaret Rees, EMAS position statement: Individualized breast cancer screening versus population-based mammography screening programmes, Maturitas, 2014,

    CrossRef

  3. 3
    Sarah McLaughlin, Elizabeth A. Mittendorf, Richard J. Bleicher, David R. McCready, Tari A. King, The 2013 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: MRI in Breast Cancer: Where Are We Now?, Annals of Surgical Oncology, 2014, 21, 1, 28

    CrossRef

  4. 4
    C.H. Lee, Annual Screening Strategies in BRCA1 and BRCA2 Gene Mutation Carriers: A Comparative Effectiveness Analysis, Breast Diseases: A Year Book Quarterly, 2013, 24, 1, 41

    CrossRef

  5. 5
    Janice S. Sung, D. David Dershaw, Breast Magnetic Resonance Imaging for Screening High-Risk Women, Magnetic Resonance Imaging Clinics of North America, 2013, 21, 3, 509

    CrossRef

  6. 6
    Ellen Warner, Breast Surveillance of Patients with BRCA1 and BRCA2 Mutations, Current Breast Cancer Reports, 2013, 5, 3, 255

    CrossRef

  7. 7
    Jessica E. Cott Chubiz, Janie M. Lee, Michael E. Gilmore, Chung Y. Kong, Kathryn P. Lowry, Elkan F. Halpern, Pamela M. McMahon, Paula D, Ryan, G. Scott Gazelle, Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers, Cancer, 2013, 119, 6
  8. 8
    B. G. Haffty, C. Lee, Exposure to diagnostic levels of radiation prior to age 30 increases the risk of breast cancer in BRCA1/2 carriers, Evidence-Based Medicine, 2013, 18, 4, e40

    CrossRef

  9. 9
    Dana Meaney-Delman, Cecelia A. Bellcross, Hereditary Breast/Ovarian Cancer Syndrome, Obstetrics and Gynecology Clinics of North America, 2013, 40, 3, 475

    CrossRef

  10. 10
    Mary C. Mahoney, Mary S. Newell, Screening MR Imaging Versus Screening Ultrasound, Magnetic Resonance Imaging Clinics of North America, 2013, 21, 3, 495

    CrossRef

  11. 11
    Laura Curr Beamer, Lauri Linder, Bohua Wu, Julia Eggert, The Impact of Genomics on Oncology Nursing, Nursing Clinics of North America, 2013, 48, 4, 585

    CrossRef

  12. 12
    J.O. Murphy, V.S. Sacchini, Utilization of Sentinel Lymph Node Biopsy in Patients with Ductal Carcinoma In Situ Undergoing Mastectomy, Breast Diseases: A Year Book Quarterly, 2013, 24, 4, 372

    CrossRef

  13. 13
    J. Desreux, V. Bleret, E. Lifrange, Should we individualize breast cancer screening?, Maturitas, 2012, 73, 3, 202

    CrossRef